These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study. Reddy VY; Dukkipati SR; Neuzil P; Natale A; Albenque JP; Kautzner J; Shah D; Michaud G; Wharton M; Harari D; Mahapatra S; Lambert H; Mansour M Circulation; 2015 Sep; 132(10):907-15. PubMed ID: 26260733 [TBL] [Abstract][Full Text] [Related]
27. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL; Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922 [TBL] [Abstract][Full Text] [Related]
28. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Reynolds MR; Walczak J; White SA; Cohen DJ; Wilber DJ Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):615-23. PubMed ID: 20940250 [TBL] [Abstract][Full Text] [Related]
29. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial. Steinberg JS; Shabanov V; Ponomarev D; Losik D; Ivanickiy E; Kropotkin E; Polyakov K; Ptaszynski P; Keweloh B; Yao CJ; Pokushalov EA; Romanov AB JAMA; 2020 Jan; 323(3):248-255. PubMed ID: 31961420 [TBL] [Abstract][Full Text] [Related]
30. Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study. Pak HN; Park J; Park JW; Yang SY; Yu HT; Kim TH; Uhm JS; Choi JI; Joung B; Lee MH; Kim YH; Shim J Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008531. PubMed ID: 32755396 [TBL] [Abstract][Full Text] [Related]
31. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting. Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608 [TBL] [Abstract][Full Text] [Related]
32. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. Forleo GB; Mantica M; De Luca L; Leo R; Santini L; Panigada S; De Sanctis V; Pappalardo A; Laurenzi F; Avella A; Casella M; Dello Russo A; Romeo F; Pelargonio G; Tondo C J Cardiovasc Electrophysiol; 2009 Jan; 20(1):22-8. PubMed ID: 18775050 [TBL] [Abstract][Full Text] [Related]
33. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study. Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681 [TBL] [Abstract][Full Text] [Related]
34. Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial. Verma A; Haines DE; Boersma LV; Sood N; Natale A; Marchlinski FE; Calkins H; Sanders P; Packer DL; Kuck KH; Hindricks G; Onal B; Cerkvenik J; Tada H; DeLurgio DB; Circulation; 2023 May; 147(19):1422-1432. PubMed ID: 36877118 [TBL] [Abstract][Full Text] [Related]
35. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232 [TBL] [Abstract][Full Text] [Related]
36. Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy. Willems R; Wyse DG; Gillis AM; J Cardiovasc Electrophysiol; 2003 Dec; 14(12):1296-301. PubMed ID: 14678104 [TBL] [Abstract][Full Text] [Related]
37. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Brignole M; Gianfranchi L; Menozzi C; Alboni P; Musso G; Bongiorni MG; Gasparini M; Raviele A; Lolli G; Paparella N; Acquarone S Circulation; 1997 Oct; 96(8):2617-24. PubMed ID: 9355902 [TBL] [Abstract][Full Text] [Related]
38. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. Natale A; Reddy VY; Monir G; Wilber DJ; Lindsay BD; McElderry HT; Kantipudi C; Mansour MC; Melby DP; Packer DL; Nakagawa H; Zhang B; Stagg RB; Boo LM; Marchlinski FE J Am Coll Cardiol; 2014 Aug; 64(7):647-56. PubMed ID: 25125294 [TBL] [Abstract][Full Text] [Related]
39. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data. Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878 [TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. Turco P; De Simone A; La Rocca V; Iuliano A; Capuano V; Astarita C; Di Napoli T; Messina V; Baldi S; Stabile G Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S112-5. PubMed ID: 17302684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]